Does the clamping method in local and systemic TXA applications in total knee arthroplasty change the game?: A retrospective comparative cohort study

Many different methods and drain clamping periods have been described in systemic and local tranexamic acid (TXA) applications, and the superiority of the methods to each other has not been clearly demonstrated. The method of local infusion in combined TXA applications may not alter the Hb drop or total or hidden blood loss. We aim to compare two different combined TXA application methods. We retrospectively analyzed 182 patients who underwent total knee arthroplasty between 2018 and 2021. Patients over 40 years of age who underwent TKA for degenerative knee arthritis were included in the study. Unicondylar, revision, or bilateral arthroplasties and patients with the cardiovascular or cerebrovascular disease were excluded from the study. All patients in the study received 1 g TXA intravenously half an hour before the incision. For the first group, 1 g TXA was given intra-articularly at the drain site after closure, and the clamp was kept closed for 1 hour. In the second group, the drain was clamped for an additional 6 hours, and a 1 g intravenous dose was administered at the 5th hour postoperatively. No local applications were used in the control group. Total, hidden, and visible blood loss (total blood loss, hidden blood loss, visible blood loss), postoperative decreases in hemoglobin and hematocrit level (ΔHgb, ΔHtc), blood transfusion rates, and hospital stay durations were evaluated. There were 72 patients in the first group, 52 in the second, and 58 in control. A total of 37 patients received one or more blood transfusions postoperatively, and there was no statistical difference in the need for blood transfusions between the groups (P = .255). Although a statistically significant difference (P = .001) in total blood loss, hidden blood loss, visible blood loss and ΔHgb values was observed between the groups, the difference between the first and second groups was insignificant (P = .512). The duration of hospital stay was observed to be less in the first and second groups (P = .024). Local and systemic TXA applications were observed to be more effective than only systemic applications in reducing blood loss after total knee arthroplasty, regardless of the local method.

[1]  M. Hantes,et al.  Octogenarians Are the New Sexagenarians: Cruciate-Retaining Total Knee Arthroplasty Is Not Inferior to Posterior-Stabilized Arthroplasty in Octogenarian Patients , 2022, Journal of clinical medicine.

[2]  Wei Huang,et al.  Not all patients benefit from the postoperative antifibrinolytic treatment: clinical evidence against the universal use of tranexamic acid following total knee arthroplasty , 2022, Journal of Orthopaedic Surgery and Research.

[3]  Wei Huang,et al.  Efficacy of a three-day prolonged-course of multiple-dose versus a single-dose of tranexamic acid in total hip and knee arthroplasty , 2020, Annals of translational medicine.

[4]  M. Grecula CORR Insights®: Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial. , 2019, Clinical orthopaedics and related research.

[5]  D. Tong,et al.  Hidden blood loss after hip hemiarthroplasty using the superPATH approach: A retrospective study. , 2019, Injury.

[6]  Bo Yang,et al.  Combined intravenous and intra-articular tranexamic acid administration in total knee arthroplasty for preventing blood loss and hyperfibrinolysis , 2019, Medicine.

[7]  Jiang Chen,et al.  Comparison of intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee and hip arthroplasty: a meta-analysis of randomised controlled trials , 2019, BMJ Open.

[8]  T. Rasmussen,et al.  Fibrinolysis in trauma: a review , 2018, European Journal of Trauma and Emergency Surgery.

[9]  David B Hoyt,et al.  Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. , 2015, JAMA.

[10]  A. Rasi,et al.  Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty. , 2014, The Journal of arthroplasty.

[11]  M. Vasso,et al.  Knee flexion after total knee arthroplasty reduces blood loss , 2014, Knee Surgery, Sports Traumatology, Arthroscopy.

[12]  M. Pagnano,et al.  Low Risk of Thromboembolic Complications With Tranexamic Acid After Primary Total Hip and Knee Arthroplasty , 2013, Clinical orthopaedics and related research.

[13]  Sumit Jain,et al.  Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty , 2012, Knee Surgery, Sports Traumatology, Arthroscopy.

[14]  R. Maniar,et al.  Most Effective Regimen of Tranexamic Acid in Knee Arthroplasty: A Prospective Randomized Controlled Study in 240 Patients , 2012, Clinical orthopaedics and related research.

[15]  Jun-Wen Wang,et al.  Does Tranexamic Acid Save Blood in Minimally Invasive Total Knee Arthroplasty? , 2011, Clinical orthopaedics and related research.

[16]  T. Matsushita,et al.  Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty , 2011, International Orthopaedics.

[17]  F. Chung,et al.  Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. , 2010, The Journal of bone and joint surgery. American volume.

[18]  J. Eubanks Antifibrinolytics in Major Orthopaedic Surgery , 2010, The Journal of the American Academy of Orthopaedic Surgeons.

[19]  J. Douketis,et al.  Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. , 2009, Thrombosis research.

[20]  J. Cid,et al.  Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta‐analysis of randomized controlled trials , 2005, Transfusion.

[21]  P. Calder,et al.  The use of tranexamic acid to reduce blood loss during total knee arthroplasty. , 2003, The Knee.

[22]  K. Ho,et al.  Use of Intravenous Tranexamic Acid to Reduce Allogeneic Blood Transfusion in Total Hip and Knee Arthroplasty: A Meta-analysis , 2003, Anaesthesia and intensive care.

[23]  L. Good,et al.  Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. , 2003, British journal of anaesthesia.

[24]  F. Madsen,et al.  Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study , 2002, Acta anaesthesiologica Scandinavica.

[25]  R. Abbate,et al.  Effect of Tourniquet Use on Activation of Coagulation in Total Knee Replacement , 2000, Clinical orthopaedics and related research.

[26]  C Longstaff,et al.  Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[27]  Alan H. Todd Arthroplasty , 1923, Definitions.

[28]  P. Meshram,et al.  Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial. , 2019, Clinical orthopaedics and related research.

[29]  Walid Mohamed Emara,et al.  Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty , 2014, Anesthesia, essays and researches.

[30]  C. Samama,et al.  Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study. , 2013, Thrombosis research.

[31]  I. Nilsson Clinical pharmacology of aminocaproic and tranexamic acids , 1980, Journal of clinical pathology. Supplement.

[32]  Å. Ahlberg,et al.  Diffusion of tranexamic acid to the joint. , 1976, Acta Orthopaedica Scandinavica.